Back To Product:

Effective Treatment of Lyme Borreliosis with Pentacyclic Alkaloid Uncaria tomentosa (TOA-free Cat’s Claw)

Introduction. In a six-month prospective cohort study designed to compare the effectiveness of an alternative method of Lyme borreliosis treatment to conventional antibiotic treatment, patients receiving alternative treatment showed greater improvement based on self-reported disease symptoms, physician evaluation and clinical laboratory tests. The alternative treatment consisted of the use of Pentacyclic Alkaloid Chemotype Uncaria tomentosa, or TOA-Free Cat’s Claw, dietary and lifestyle changes, enzymes, vitamins, minerals, detoxification herbs and body pH-balancing. Conventional treatment included antibiotic treatment as recommended by the American Medical Association. 

Structure of Study. Twenty-eight patients with advanced Lyme borreliosis entered the study, one patient dropped out due to hospitalization and surgery for an unrelated pelvic tumor, and twenty-seven patients completed the study. The presence of the IgG and IgM antibodies to Borrelia burgdorferi and clinical evaluation confirmed each patient’s diagnosis. Each person had had the disease for over 10 years, had experienced progressive deterioration and had shown very little or no clinical improvement with long-term and/or repeated courses of antibiotics.